You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Novel, Point-of-Care, Multi-Analysis Platelet Function Diagnostic System

    SBC: LYNNTECH INC.            Topic: DHP13013

    Platelets play a central role in hemostasis and are responsible for many inherited and acquired bleeding disorders and thrombic events in human beings. A significant portion of post-trauma deaths are related to coagulopathy or hemorrhage events for both injured soldiers and civilian patients. Several platelet function analyzers have been designed and developed; however due to form-factor and/or ...

    SBIR Phase II 2015 Department of DefenseDefense Health Agency
  2. Antimicrobial Protective Silicone and Carbon Based Wound Dressings

    SBC: LYNNTECH INC.            Topic: DHP13014

    Timely management and closure of burn wounds are critical for proper emergency care and the assurance of positive outcomes for the warfighter. Current technologies rely on reagents that cannot respond effectively to the different classes of pathogens that

    SBIR Phase II 2015 Department of DefenseDefense Health Agency
  3. Blood Brain Barrier (BBB) Permeable Encapsulating Agents for Effective Delivery of CNS-active Agents

    SBC: LYNNTECH INC.            Topic: CBD08107

    Drug transport in the central nervous system is highly regulated by the Blood-Brain Barrier (BBB). Most medicines, including many for treating cancer, Alzheimer’s, and stroke, do not meet essential criteria, such as lipophilicity and low molecular weight, required for appreciable transport into the brain. However, endogenous peptides, such as insulin or transferrin, and certain monoclonal anti ...

    SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense
  4. Burkholderia antibody molecules for therapeutics and diagnostics

    SBC: BIOO SCIENTIFIC CORPORATION            Topic: CBD14105

    Burkholderia pseudomallei and Burkholderia mallei are highly pathogenic Gram - negative bacteria and the causative agents of melioidosis and glanders, respectively. These infections, which occur in humans and other animals, are endemic is wide regions of the developing world. This Phase II SBIR project will build on the success of our Phase I work, which established methods for generating monoclon ...

    SBIR Phase II 2015 Department of DefenseOffice for Chemical and Biological Defense
  5. Carbon Nanotube-Based Filters for Aerosol Sample Collection

    SBC: AGAVE BIOSYSTEMS INC.            Topic: CBD07111

    Aerosols represent one of the more efficient methods to distribute biological and chemical agents throughout the atmosphere. Small aerosol droplets can be readily inhaled and easily penetrate deep into the lungs where they lodge in bronchial alveoli. Within the alveoli, chemical and biological agents can breach epithelial and endothelial cell layers and enter the bloodstream, where they cause da ...

    SBIR Phase I 2007 Department of DefenseOffice for Chemical and Biological Defense
  6. Collective Protection for Military Working Dogs

    SBC: AGAVE BIOSYSTEMS INC.            Topic: CBD08103

    Shelter enclosures for military working dogs in the event of a CB attack is a technology gap identified by the Joint Requirements Office. Important parameters to consider in the design of protective enclosures include low weight and size to minimize transport requirements; rapid setup; and accommodation of canine physiological and psychological comfort needs. The overall operational weight of th ...

    SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense
  7. Data Integration and Predictive Analysis System (IPAS)

    SBC: KNOWLEDGE BASED SYSTEMS INC            Topic: DHP15008

    KBSI proposes to design and develop a Data Integration and Predictive Analysis System (IPAS) for the prediction of incidents of human infectious diseases. IPAS will utilize innovative collection of data from open data sources, veterinary and medical professionals, and public observations, together with data cleaning, harmonization, spatio-temporal pattern extraction, factor analysis, and predicti ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
  8. Development of Extracellular Matrices for Cranioplasty Applications

    SBC: FABRICO TECHNOLOGY, INC.            Topic: DHP13012

    In this Phase I program, Fabrico Technology, Professor Leonid Bunegin of the University of Texas Health Science Center at San Antonio (UTHSC-SA), and Dr. Rocco Armonda, Director, Neuroendovascular Surgery and Neurotrauma, MedStar-Georgetown University Hos

    SBIR Phase II 2015 Department of DefenseDefense Health Agency
  9. Imidazenil: A Protective Agent Against Chemical Warfare Agents induced Status Epilepticus

    SBC: NEUPHARMA, INC.            Topic: CBD05116

    The overall objective of this Phase II proposal is to determine the advantages of imidazenil over diazepam or midazolam as a potential anticonvulsant agent for the prophylaxis and for the emergency treatment of organophosphate nerve agent exposure. Therefore, we will compare the dose-dependent efficacy and anticonvulsant tolerance liability of imidazenil or midazolam for protecting rats against di ...

    SBIR Phase II 2007 Department of DefenseOffice for Chemical and Biological Defense
  10. Microfluidic Real-Time Monitoring Array with Graphene Enhanced Impedance Sensing for Coagulation Biomarker Profiling

    SBC: LYNNTECH INC.            Topic: DHP15012

    About 40% of trauma-related deaths are related to rapid onset of coagulopathy and the vast majority of trauma patients are coagulopathic at the time of death. Lynntech proposes to develop a novel, easy-to-use and cost effective device for simultaneous quantitative real-time detection of multiple proteins involved in the hemostatic mechanism, using human unprocessed whole blood as the input sample. ...

    SBIR Phase I 2015 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government